Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Buonaguro

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Cancers|December 16, 2020
Human Hepatocellular Carcinoma (HCC)Luigi Buonaguro
Hepatobiliary Surgery and Nutrition|January 9, 2015
TIE2-expressing monocytes: a possible cellular diagnostic and prognostic biomarker for hepatocellular carcinomaLuigi Buonaguro
Cancer Immunology, Immunotherapy : CII|June 22, 2015
Developments in cancer vaccines for hepatocellular carcinomaLuigi Buonaguro,
Current HIV Research|May 14, 2010
Novel vaccines and adjuvantsLuigi Buonaguro
Cytokine & Growth Factor Reviews|July 10, 2017
New vaccination strategies in liver cancerLuigi Buonaguro,
Cytokine & Growth Factor Reviews|September 19, 2017
Corrigendum to "New vaccination strategies in liver cancer" [Cytokine Growth Factor Rev. 36 (2017) 125-129]Luigi Buonaguro,
Immunological Reviews|January 5, 2011
Immunogenomics and systems biology of vaccinesLuigi Buonaguro, Bali Pulendran
Frontiers in Oncology|November 4, 2022
The impact of antigenic molecular mimicry on anti-cancer T-cell immune responseMaria Tagliamonte, Luigi Buonaguro
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Pathogens: Our Allies against Cancer?Luigi Buonaguro, Vincenzo Cerullo
Frontiers in Immunology|November 15, 2023
Corrigendum: Peptide-based vaccine for cancer therapiesLuigi Buonaguro, Maria Tagliamonte
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Cancers|December 16, 2020
Human Hepatocellular Carcinoma (HCC)Luigi Buonaguro
Hepatobiliary Surgery and Nutrition|January 9, 2015
TIE2-expressing monocytes: a possible cellular diagnostic and prognostic biomarker for hepatocellular carcinomaLuigi Buonaguro
Cancer Immunology, Immunotherapy : CII|June 22, 2015
Developments in cancer vaccines for hepatocellular carcinomaLuigi Buonaguro,
Current HIV Research|May 14, 2010
Novel vaccines and adjuvantsLuigi Buonaguro
Cytokine & Growth Factor Reviews|July 10, 2017
New vaccination strategies in liver cancerLuigi Buonaguro,
Cytokine & Growth Factor Reviews|September 19, 2017
Corrigendum to "New vaccination strategies in liver cancer" [Cytokine Growth Factor Rev. 36 (2017) 125-129]Luigi Buonaguro,
Immunological Reviews|January 5, 2011
Immunogenomics and systems biology of vaccinesLuigi Buonaguro, Bali Pulendran
Frontiers in Oncology|November 4, 2022
The impact of antigenic molecular mimicry on anti-cancer T-cell immune responseMaria Tagliamonte, Luigi Buonaguro
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2020
Pathogens: Our Allies against Cancer?Luigi Buonaguro, Vincenzo Cerullo
Frontiers in Immunology|November 15, 2023
Corrigendum: Peptide-based vaccine for cancer therapiesLuigi Buonaguro, Maria Tagliamonte
Pageof 18